Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 9/20 | 0.80 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.80 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5579685 | 1.00 | HDAC2 (0.80) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5077639 | 0.89 | HDAC6 (1.00) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5075739 | 0.89 | HDAC6 (1.00) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5075731 | 0.89 | HDAC6 (1.00) | HDAC2HDAC8HDAC6 | |
| SCHEMBL8246546 | 0.89 | HDAC2 (0.68) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5078965 | 0.84 | HDAC2 (0.76) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5078964 | 0.84 | HDAC2 (0.76) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5284313 | 0.81 | HDAC2 (0.65) | HDAC2HDAC8HDAC6 | |
| SCHEMBL5284317 | 0.81 | HDAC2 (0.65) | HDAC2HDAC8HDAC6 | |
| SCHEMBL14472814 | 0.81 | HDAC6 (0.81) | HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070155730-A1 | Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase | METHYLGENE, INC. (CA) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155730-A1 | Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase | HDAC5, HDAC4, HDAC3 | HDAC2 4/4885HDAC8 9/4885HDAC6 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.